T5	Effect 216 242	hemolytic-uremic syndrome.
T6	Treatment 16 28;79 115	chemotherapy at the beginning of the fourth cycle
T7	Subject 117 128	the patient
T8	Drug 16 28	chemotherapy
T9	Duration 103 115	fourth cycle
T4	Adverse_event 129 138	developed
E1	Adverse_event:T4